Synthetic PreImplantation Factor

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
95	自己免疫性肝炎	2

95. 自己免疫性肝炎

臨床試験数 : 52 / 薬物数 : 68 - (DrugBank : 27) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 111

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03593460 (ClinicalTrials.gov)	January 1, 2019	7/6/2018	Phase II AutoImmune Hepatitis	Phase II, Open Label, Adaptive Design, Multiple Dose Finding Study to Investigate Synthetic PreImpla ...	Hepatitis, Autoimmune	Drug: Synthetic PreImplantation Factor	Christopher O'Brien, MD	BioIncept LLC	Withdrawn	18 Years	75 Years	All	0	Phase 2	NULL
2	NCT02239562 (ClinicalTrials.gov)	November 14, 2014	10/9/2014	sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS	A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to ...	Autoimmune Hepatitis	Drug: sPIF;Drug: Placebo	Christopher O'Brien, MD	BioIncept LLC	Completed	18 Years	70 Years	Female	36	Phase 1	United States

First Previous1Next Last